IQ
Company · RAPP · listed in US

ETFs that hold Rapport Therapeutics

Share
Share on XDownload as PDF

40 thematic and core ETFs hold Rapport Therapeutics, by holdings dated Jun 30, 2026 to Nov 3, 2026. SBIO holds the most, at 1.19% of the fund on Aug 31, 2026. The next largest are IBRN (1.12%) and XPH (1.11%).

askIQ about this page

askIQ about Rapport Therapeutics

1 income and other fund on it is listed below.

Look up another companyaskIQ about who holds RAPP
Share of each fund · one bar per fund, largest first
SBIO 1.19%40 fundsVTHR <0.01%
0
funds above 10%
0.03%
median share
37
funds under 1%

Thematic and core funds that hold it

40 funds
40 of 40 · click a column to sort
ETFs that hold Rapport Therapeutics
#FundNameShare of the fund ↓Holdings filedAsset
1SBIOALPS Medical Breakthroughs ETF1.19%Aug 31, 2026Equity
2IBRNiShares Neuroscience and Healthcare ETF1.12%Nov 3, 2026Equity
3XPHState Street SPDR S&P Pharmaceuticals ETF1.11%Nov 3, 2026Equity
4BBCVirtus Biotech Clinical Trials ETF0.71%Jul 31, 2026Equity
5DWASInvesco Dorsey Wright SmallCap Momentum ETF0.40%Nov 3, 2026Equity
6IHEiShares U.S. Pharmaceuticals ETF0.23%Nov 3, 2026Equity
7TMEDT. Rowe Price Health Care ETF0.20%Jun 30, 2026Equity
8IWCiShares Micro-Cap ETF0.19%Nov 3, 2026Equity
9ESSCEventide Small Cap ETF0.17%Jul 31, 2026Equity
10KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.13%Jul 31, 2026Equity
11VFMOVanguard U.S. Momentum Factor ETF0.11%Sep 30, 2026Equity
12TNXTT. Rowe Price Innovation Leaders ETF0.11%Jun 30, 2026Equity
13RFLRInnovator U.S. Small Cap Managed Floor ETF0.10%Jul 31, 2026Equity
14NUSCNuveen ESG Small-Cap ETF0.09%Jul 31, 2026Equity
15IBBQInvesco Nasdaq Biotechnology ETF0.08%Nov 3, 2026Equity
16VTWGVanguard Russell 2000 Growth ETF0.06%Sep 30, 2026Equity
17AVSCAvantis U.S. Small Cap Equity ETF0.05%Nov 2, 2026Equity
18IBBiShares Biotechnology ETF0.05%Nov 3, 2026Equity
19IWOiShares Russell 2000 Growth ETF0.05%Nov 3, 2026Equity
20RSSLGlobal X Russell 2000 ETF0.04%Jul 31, 2026Equity
21VTWOVanguard Russell 2000 ETF0.03%Sep 30, 2026Equity
22IWMiShares Russell 2000 ETF0.03%Nov 3, 2026Equity
23SCHASchwab U.S. Small-Cap ETF0.03%Aug 31, 2026Equity
24GSSCGS ActiveBeta U.S. Small Cap Equity ETF0.03%Aug 31, 2026Equity
25ISCViShares Morningstar Small-Cap Value ETF0.03%Nov 3, 2026Equity
26ISCB(name not filed)0.02%Jul 31, 2026Equity
27DFASU.S. Small Cap Portfolio: ETF Class Shares0.02%Jul 31, 2026Equity
28FHLCFidelity MSCI Health Care Index ETF0.02%Jul 31, 2026Equity
29VXFVanguard Extended Market ETF0.01%Sep 30, 2026Equity
30VHTVanguard Health Care ETF0.01%Sep 30, 2026Equity
31MSMLiShares MSCI USA Small-Cap ETF0.01%Nov 3, 2026Equity
32WSMLiShares MSCI World Small-Cap ETF0.01%Nov 3, 2026Equity
33MSSMMorgan Stanley Pathway Small-Mid Cap Equity ETF0.01%Aug 31, 2026Equity
34ONEQFidelity Nasdaq Composite Index ETF0.01%Aug 31, 2026Equity
35VTWVVanguard Russell 2000 Value ETF0.01%Sep 30, 2026Equity
36IWNiShares Russell 2000 Value ETF<0.01%Nov 3, 2026Equity
37SCHBSchwab U.S. Broad Market ETF<0.01%Aug 31, 2026Equity
38VTIVanguard Morningstar Total Stock Market ETF<0.01%Sep 30, 2026Equity
39FESMFidelity Enhanced Small Cap Core ETF<0.01%Jun 30, 2026Equity
40VTHRVanguard Russell 3000 ETF<0.01%Sep 30, 2026Equity
As of Nov 5, 2026. Source: each fund's own holdings.

Income and other funds that hold it

Income and other funds that hold it
#FundNameShare of the fundHoldings filedCategory
1ITWOProShares Russell 2000 High Income ETF0.04%Aug 31, 2026Income
As of Nov 5, 2026. Source: each fund's own holdings.

How we count

Rapport Therapeutics (ticker RAPP, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name.

Amber dates are more than a quarter old; the fund may have traded since.

How books are read →
Where to next
Look up another company→
Themes that hold it: Biotech, Broad innovation and megatrends, Therapeutics and medical devices→
See what a portfolio holds, company by company→

Questions people ask

Which ETFs hold Rapport Therapeutics?
40 thematic and core ETFs hold Rapport Therapeutics, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are SBIO at 1.19% of the fund on Aug 31, 2026, IBRN at 1.12% of the fund on Nov 3, 2026 and XPH at 1.11% of the fund on Nov 3, 2026. 1 income and other fund on it is listed apart.
Sources and dates
HoldingsSEC Form N-PORT, what a fund filed it holds ↗
FilingsSEC EDGAR, full-text search of fund filings ↗

Links go to the source documents. ETFIQ is an independent publisher and makes no recommendations. Standards and sources →

Cite this pageCitation, APA and Markdown

ETFIQ, ETFs holding RAPPORT THERAPEUTICS, data as of Nov 5, 2026. https://etfiq.com/holdings/rapp/

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.